SP1 and prostate carcinoma: These tumours resulted from genetic alterations to important signalling pathways in prostate cancer, making them clinically highly relevant.10,11 CP2 and SP1 cells signify carcinogenesis driven by WNT and Ras-MAPK pathways, respectively (Supplementary Fig. S1A).